• Menu ☰
Trending :

Param Desai

Param Desai


Home  > Param Desai

You Searched For "Param Desai"

PL Stock Report: J.B. Chemicals & Pharmaceuticals (JBCP IN) - Event Update – Entry into high growing opthal segment - BUY26 Dec 2023 10:27 AM IST

PL Stock Report: J.B. Chemicals & Pharmaceuticals (JBCP IN) - Event Update – Entry into high growing opthal...

PL Stock Report: Aster DM Healthcare (ASTERDM IN) - Event Update – GCC stake sale to unlock value - BUY1 Dec 2023 10:46 AM IST

PL Stock Report: Aster DM Healthcare (ASTERDM IN) - Event Update – GCC stake sale to unlock value - BUY

PL Stock Report - Apollo Hospitals Enterprise (APHS IN) - Q2FY24 Result Update - Strong show in hospital segment - BUY13 Nov 2023 11:37 AM IST

PL Stock Report - Apollo Hospitals Enterprise (APHS IN) - Q2FY24 Result Update - Strong show in hospital...

PL Stock Report - HealthCare Global Enterprises (HCG IN) - Q2FY24 Result Update - In-line EBITDA; scale up in margins is key - BUY
PL Stock Report - HealthCare Global Enterprises (HCG IN) - Q2FY24 Result Update - In-line EBITDA; scale up in margins is key - BUY 13 Nov 2023 11:29 AM IST
PL Stock Report - Aurobindo Pharma (ARBP IN) - Q2FY24 Result Update - Strong quarter; US to further scale up - Accumulate
PL Stock Report - Aurobindo Pharma (ARBP IN) - Q2FY24 Result Update - Strong quarter; US to further scale up - Accumulate 13 Nov 2023 11:22 AM IST
PL Stock Report - Ipca Laboratories (IPCA IN) - Q2FY24 Result Update - In line EBITDA; Unichem integration and US scale up is key - HOLD
PL Stock Report - Ipca Laboratories (IPCA IN) - Q2FY24 Result Update - In line EBITDA; Unichem integration and US scale up is key - HOLD 13 Nov 2023 10:31 AM IST
PL Stock Report: Eris Lifesciences (ERIS IN) - Q2FY24 Result Update – In-line EBITDA; Strengthening its derma portfolio - BUY
PL Stock Report: Eris Lifesciences (ERIS IN) - Q2FY24 Result Update – In-line EBITDA; Strengthening its derma portfolio - BUY 10 Nov 2023 12:17 PM IST
PL Stock Report: Krishna Institute of Medical Sciences (KIMS IN) - Q2FY24 Result Update – In-line EBITDA; Expansion plans slightly delayed - BUY
PL Stock Report: Krishna Institute of Medical Sciences (KIMS IN) - Q2FY24 Result Update – In-line EBITDA; Expansion plans slightly delayed - BUY 9 Nov 2023 10:21 AM IST
PL Stock Report: J.B. Chemicals & Pharmaceuticals (JBCP IN) - Q2FY24 Result Update – Margin surprise - BUY
PL Stock Report: J.B. Chemicals & Pharmaceuticals (JBCP IN) - Q2FY24 Result Update – Margin surprise - BUY 9 Nov 2023 10:19 AM IST
PL Stock Report: Zydus Lifesciences (ZYDUSLIF IN) - Q2FY24 Reuslt Update – Healthy margins despite lower gRevlimid sales - Accumulate
PL Stock Report: Zydus Lifesciences (ZYDUSLIF IN) - Q2FY24 Reuslt Update – Healthy margins despite lower gRevlimid sales - Accumulate 8 Nov 2023 10:36 AM IST
PL Stock Report: Divis Laboratories (DIVI IN) - Q2FY24 Result Update – Margins dip amid pricing pressure - REDUCE
PL Stock Report: Divi's Laboratories (DIVI IN) - Q2FY24 Result Update – Margins dip amid pricing pressure - REDUCE 7 Nov 2023 11:41 AM IST
PL Stock Report: Sun Pharmaceutical Industries (SUNP IN) - Q2FY24 Result Update – In-line quarter aided by specialty and domestic formulation - BUY
PL Stock Report: Sun Pharmaceutical Industries (SUNP IN) - Q2FY24 Result Update – In-line quarter aided by specialty and domestic formulation - BUY 2 Nov 2023 11:27 AM IST
PL Stock Report: Cipla (CIPLA IN) - Q2FY24 Result Update – Another quarter of higher margins and US sales - BUY
PL Stock Report: Cipla (CIPLA IN) - Q2FY24 Result Update – Another quarter of higher margins and US sales - BUY 30 Oct 2023 11:58 AM IST
Prabhudas Lilladher Pvt Ltd
PL Stock Report: Dr. Reddy's Laboratories (DRRD IN) - Q2FY24 Result Update – In line EBITDA aided by gRevlimid and PLI incentives - REDUCE 30 Oct 2023 10:33 AM IST
Prabhudas Lilladher Pvt Ltd
PL Stock Report: Torrent Pharmaceuticals (TRP IN) - Q2FY24 Result Update – Strong show across its key branded generic markets - BUY 25 Oct 2023 10:47 AM IST
PL Stock Report: Sunteck Realty (SRIN IN) - Q2FY24 Result Update – Steady quarter; new launches and project additions to step up - BUY
PL Stock Report: Sunteck Realty (SRIN IN) - Q2FY24 Result Update – Steady quarter; new launches and project additions to step up - BUY 25 Oct 2023 10:46 AM IST
PL Stock Report: Indoco Remedies (INDR IN) - Q2FY24 Result Update – Margins to improve - BUY
PL Stock Report: Indoco Remedies (INDR IN) - Q2FY24 Result Update – Margins to improve - BUY 20 Oct 2023 10:14 AM IST
PL Sector Report: Healthcare - Jul-Sep’23 Earnings Preview – Margins to sustain
PL Sector Report: Healthcare - Jul-Sep’23 Earnings Preview – Margins to sustain 9 Oct 2023 11:51 AM IST
PL Stock Report: Alembic Pharmaceuticals (ALPM IN) - Management Meet Update - US sales and profitability to improve - Not Rated
PL Stock Report: Alembic Pharmaceuticals (ALPM IN) - Management Meet Update - US sales and profitability to improve - Not Rated 25 Aug 2023 3:38 PM IST
PL Stock Report: Aster DM Healthcare (ASTERDM IN) - Q1FY24 Result Update - Strong growth across GCC segments - BUY
PL Stock Report: Aster DM Healthcare (ASTERDM IN) - Q1FY24 Result Update - Strong growth across GCC segments - BUY 16 Aug 2023 10:05 AM IST
PL Stock Report: HealthCare Global Enterprises (HCG IN) - Q1FY24 Result Update - Margins to improve - BUY
PL Stock Report: HealthCare Global Enterprises (HCG IN) - Q1FY24 Result Update - Margins to improve - BUY 14 Aug 2023 11:35 AM IST
PL Stock Report: Apollo Hospitals Enterprise (APHS IN) - Q1FY24 Result Update - In-line quarter; occupancy to pick up - BUY
PL Stock Report: Apollo Hospitals Enterprise (APHS IN) - Q1FY24 Result Update - In-line quarter; occupancy to pick up - BUY 14 Aug 2023 10:34 AM IST
PL Stock Report: Zydus Lifesciences (ZYDUSLIF IN) - Q1FY24 Result Update - Higher gRevlimid sales aided the quarter - Accumulate
PL Stock Report: Zydus Lifesciences (ZYDUSLIF IN) - Q1FY24 Result Update - Higher gRevlimid sales aided the quarter - Accumulate 14 Aug 2023 10:26 AM IST
Prabhudas Lilladher Pvt Ltd
PL Stock Report: Ipca Laboratories (IPCA IN) - Q1FY24 Result Update - Mixed bag - Margin recovery while muted export business - HOLD 14 Aug 2023 10:09 AM IST
PL Stock Report: J.B. Chemicals & Pharmaceuticals (JBCP IN) - Q1FY24 Result Update - Strong quarter; margins to sustain - BUY
PL Stock Report: J.B. Chemicals & Pharmaceuticals (JBCP IN) - Q1FY24 Result Update - Strong quarter; margins to sustain - BUY 11 Aug 2023 12:21 PM IST
PL Stock Report: Max Healthcare Institute (MAXHEALT IN) - Q1FY24 Result Update - Strong performance in seasonally weak quarter - BUY
PL Stock Report: Max Healthcare Institute (MAXHEALT IN) - Q1FY24 Result Update - Strong performance in seasonally weak quarter - BUY 9 Aug 2023 2:16 PM IST
PL Stock Report: Eris Lifesciences (ERIS IN) - Q1FY24 Result Update - Strong margin show; Focus on organic growth - BUY
PL Stock Report: Eris Lifesciences (ERIS IN) - Q1FY24 Result Update - Strong margin show; Focus on organic growth - BUY 8 Aug 2023 12:11 PM IST
PL Stock Report: Fortis Healthcare (FORH IN) - Q1FY24 Result Update - Hospital EBIDTA miss; occupancy to improve - BUY
PL Stock Report: Fortis Healthcare (FORH IN) - Q1FY24 Result Update - Hospital EBIDTA miss; occupancy to improve - BUY 8 Aug 2023 10:28 AM IST
PL Stock Report: Torrent Pharmaceuticals (TRP IN) - Q1FY24 Result Update - Margins to sustain - BUY
PL Stock Report: Torrent Pharmaceuticals (TRP IN) - Q1FY24 Result Update - Margins to sustain - BUY 8 Aug 2023 10:26 AM IST
PL Stock Report: Lupin (LPC IN) - Q1FY24 Result Update - Strong gross margins; US ramp up is key - HOLD
PL Stock Report: Lupin (LPC IN) - Q1FY24 Result Update - Strong gross margins; US ramp up is key - HOLD 7 Aug 2023 11:42 AM IST
PL Stock Report: Sun Pharmaceutical Industries (SUNP IN) - Q1FY24 Result Update - gRevlimid and lower other expenses aided EBITDA - BUY
PL Stock Report: Sun Pharmaceutical Industries (SUNP IN) - Q1FY24 Result Update - gRevlimid and lower other expenses aided EBITDA - BUY 4 Aug 2023 10:39 AM IST
PL Stock Report - Cipla (CIPLA IN) - Q1FY24 Result Update - Strong quarter; margins and US sales guidance revised upward - BUY
PL Stock Report - Cipla (CIPLA IN) - Q1FY24 Result Update - Strong quarter; margins and US sales guidance revised upward - BUY 27 July 2023 11:00 AM IST
PL Stock Report - Dr. Reddys Laboratories (DRRD IN) - Q1FY24 Result Update - Another quarter of higher gRevlimid sales - REDUCE
PL Stock Report - Dr. Reddy's Laboratories (DRRD IN) - Q1FY24 Result Update - Another quarter of higher gRevlimid sales - REDUCE 27 July 2023 10:11 AM IST
PL Stock Report - Indoco Remedies (INDR IN) - Q1FY24 Result Update - Another quarter of weak margins - BUY
PL Stock Report - Indoco Remedies (INDR IN) - Q1FY24 Result Update - Another quarter of weak margins - BUY 26 July 2023 3:41 PM IST
PL Stock Report - Fortis Healthcare (FORH IN) - Event Update - Divest 200 beds loss making Arcot unit - BUY
PL Stock Report - Fortis Healthcare (FORH IN) - Event Update - Divest 200 beds loss making Arcot unit - BUY 23 Jun 2023 9:25 AM IST
image
image
image

News

Company

Entertainment

All News

© 2024 Hyderabad Media House Limited/The Hans India. All rights reserved. Powered by hocalwire.com

X
sidekick